Wednesday, July 8, 2026

Drug profile · INN

demecarium bromide

demecarium bromide (HUMORSOL) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — demecarium bromide
US status
approved
Class
Route
OPHTHALMIC
Patents
0
Programs
0
Data quality
0.84

Quick answer

demecarium bromide (HUMORSOL) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN demecarium bromide
Brand HUMORSOL
Mechanism Acetylcholinesterase inhibitor
Target Acetylcholinesterase
Route OPHTHALMIC
Formulation SOLUTION/DROPS

Mechanism of action

Acetylcholinesterase inhibitor

Primary target: Acetylcholinesterase

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. benzgalantamine gluconate Acetylcholinesterase inhibitor
  2. donepezil hydrochloride Acetylcholinesterase inhibitor
  3. neostigmine methylsulfate Acetylcholinesterase inhibitor
  4. pyridostigmine bromide Acetylcholinesterase inhibitor
  5. ambenonium chloride Acetylcholinesterase inhibitor
  6. echothiophate iodide Acetylcholinesterase inhibitor

Frequently asked questions

What is demecarium bromide?

demecarium bromide (HUMORSOL) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for demecarium bromide?

HUMORSOL is a marketed brand name for demecarium bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of demecarium bromide?

demecarium bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.